Improving the anti-solid tumor efficacy of CAR-T cells by inhibiting adenosine signaling pathway

Chimeric antigen receptor T (CAR-T) cell therapy has been applied successfully in treating hematologic malignancies; however, it shows very limited efficacy in treating solid tumors. Adenosine is one of the key immunosuppressive metabolites in tumor microenvironment (TME) of solid tumors. Although t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Na, Tang, Na, Cheng, Chen, Hu, Tao, Wei, Xiaofei, Han, Weidong, Wang, Haoyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781731/
https://www.ncbi.nlm.nih.gov/pubmed/33457103
http://dx.doi.org/10.1080/2162402X.2020.1824643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781731/
https://www.ncbi.nlm.nih.gov/pubmed/33457103
http://dx.doi.org/10.1080/2162402X.2020.1824643

Ejemplares similares